Abstract
In an attempt to find an effective cancer therapy, nanotherapeutics comes onto the scene as a new therapeutic approach, which is emerging both nanotechnology and biotechnology. Nanotherapeutics offer tremendous advantages over conventional cancer therapy including prolonged drug systemic circulation half-life, targeted drug delivery and nanoparticles-based combination therapy, which result in improving drug pharmacokinetic profile and efficacy/toxicity balance. Recently, ongoing studies regarding cancer therapy are focusing on the anticancer action of various inorganic nanoparticles such as gold (AuNPs) and silver (AgNPs) nanoparticles. In fact, AgNPs have proven a potent anticancer action on different cancer types.
School
School of Sciences and Engineering
Degree Name
MS in Nanotechnology
First Advisor
Mamdouh, Wael
Second Advisor
Amleh, Asma
Committee Member 1
Siam, Rania
Committee Member 2
EL-Ghobashy, Medhat
Committee Member 3
Salem, Hanadi
Document Type
Thesis
Rights
The American University in Cairo grants authors of theses and dissertations a maximum embargo period of two years from the date of submission, upon request. After the embargo elapses, these documents are made available publicly. If you are the author of this thesis or dissertation, and would like to request an exceptional extension of the embargo period, please write to thesisadmin@aucegypt.edu
Recommended Citation
APA Citation
El-Baz, N. M.
().Developing core-shell silver/polymeric nano-composites as drug nano-carriers for breast cancer therapy [Thesis, the American University in Cairo]. AUC Knowledge Fountain.
https://fount.aucegypt.edu/retro_etds/2627
MLA Citation
El-Baz, Nancy Mohamed. Developing core-shell silver/polymeric nano-composites as drug nano-carriers for breast cancer therapy. . American University in Cairo, Thesis. AUC Knowledge Fountain.
https://fount.aucegypt.edu/retro_etds/2627